Anti-Monopoly Guidelines for the Active Pharmaceutical Ingredient Sector

关于原料药领域的反垄断指南

Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector

(Issued by the Anti-monopoly Commission of the State Council on, and effective as of, November 15, 2021.)

（国务院反垄断委员会于二零二一年十一月十五日发布施行。）

Guo Fan Long Fa [2021] No.3

国反垄发〔2021〕3号

Part One: General Provisions

第一章 总 则

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]